CVS Health is set to name David Joyner, president of CVS Caremark, as its new CEO, succeeding Karen Lynch, The Wall Street Journal’s Anna Wilde Mathews reports. He will take over as president and CEO on Friday, according to the report. Roger Farah, chairman of CVS’s board of directors, will also become executive chair. CVS is now planning to announce Q3 results that will fall short of Street expectations and to back away from its most recent guidance for 2024, issued in August. “We believe that we have a really important part to play in terms of simplifying and delivering a better healthcare experience for this country,” Joyner said. CVS’s assembled assets will allow it “to actually deliver on the promises that we’ve made, and now it’s all about execution.”
previous post